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Abstract
Background: Retroviruses have a diploid genome and recombine at high frequency. Recombinant
proviruses can be generated when two genetically different RNA genomes are packaged into the
same retroviral particle. It was shown in several studies that recombinant proviruses could be
generated in each round of HIV-1 replication, whereas the recombination rates of SNV and Mo-
MuLV are 5 to 10-fold lower. The reason for these differences is not clear. One possibility is that
these retroviruses may differ in their ability to copackage genomic RNAs produced at different
chromosomal loci.
Results: To investigate whether there is a difference in the efficiency of heterodimer formation
when two proviruses have the same or different chromosomal locations, we introduced two
different Mo-MuLV-based retroviral vectors into the packaging cell line using either the
cotransfection or sequential transfection procedure. The comparative study has shown that the
frequency of recombination increased about four-fold when the cotransfection procedure was
used. This difference was not associated with possible recombination of retroviral vectors during
or after cotransfection and the ratios of retroviral virion RNAs were the same for two variants of
transfection.
Conclusions: The results of this study indicate that a mechanism exists to enable the preferential
copackaging of Mo-MuLV genomic RNA molecules that are transcribed on the same DNA
template. The properties of Mo-MuLV genomic RNAs transport, processing or dimerization might
be responsible for this preference. The data presented in this report can be useful when designing
methods to study different aspects of replication and recombination of a diploid retroviral genome.
Background
Retroviruses are a family of RNA viruses which replicate
through a DNA intermediate [1]. The unique property of
retroviruses is that their virions contain two identical
genomic RNA molecules noncovalently linked near the 5'
ends forming a dimer [2,3]. Thus, the retroviral genome is
diploid. The presence of two RNA molecules in each vir-
ion seems to be necessary for recombination because
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there is no pool of viral replicative intermediates in the
cells infected by retroviruses [4,5]. Recombination is
thought to contribute to the genetic variability of retrovi-
ruses and to repair breaks in genomic RNA. It can not be
excluded that both RNA molecules are necessary for syn-
thesis of proviral DNA.
Reverse transcription entails two DNA strand transfers
during minus and plus DNA synthesis. Since the retroviral
virion contains two molecules of the viral RNA, the first
DNA transfer might be either intramolecular, transferring
to the same template, or intermolecular, transferring to
the other template. In the model of Spleen necrosis virus
(SNV) it was found that the minus-strand DNA transfer is
exclusively intermolecular [6], while another study dem-
onstrated the almost complete preference for intramo-
lecular minus-strand transfer [7]. However, recombinant
proviruses can undergo both interstrand and intrastrand
transfers in equal proportions [7-9]. The rate of recombi-
nation in these reports was 4% per kilobase per replica-
tion cycle [4,8] and it was not significantly increased when
the marker distance was extended to the size of the retro-
viral genome, suggesting that recombination is limited to
only a subpopulation of retroviruses [10]. On the other
hand, Human immunodeficiency virus type 1 (HIV-1)
was shown to undergo approximately two to three recom-
bination events per genome per cycle of replication [11]
and, similar to the recombinant SNV proviruses, the first
DNA strand transfer was either intra- or intermolecular
[12,13].
A reason why there are differences in the rates of recombi-
nation between HIV-1 and gammaretroviruses (SNV and
Mo-MuLV) is not known. It has been suggested that these
differences may be associated with the differences in the
template switching frequencies of retroviral reverse tran-
scriptases [11]. A recent study has shown that the rates of
intramolecular template switching for HIV-1 and Mo-
MuLV (Moloney murine leukemia virus) were very simi-
lar, indicating that the replication properties of HIV-1 and
Mo-MuLV RTs may not differ [14]. However, it is not clear
whether the same conditions are required when both
genomic RNAs are used as the template during reverse
transcription. The other possibility is that gammaretrovi-
ruses may copackage genomic RNAs produced at different
chromosomal loci by nonrandom chance [15]. In this
case, the sizes of heterodiploid and recombining subpop-
ulations of viruses may coincide.
In this study, we have investigated whether there is a pref-
erence in the formation of homodiploid virions during
the mixed retroviral infection. To explore this possibility,
we have used the forced recombination system which
included two Mo-MuLV-based retroviral vectors contain-
ing different selectable markers and one of the vectors
having a deletion of the PBS region. These vectors were
introduced into the packaging cell line using two different
methods, cotransfection, to provide tandem integration,
or sequential transfection, and the frequencies of recom-
bination for the vectors have been compared.
Results
Experimental approach
To study whether there was a preference for the formation
of homodiploid virions in the mixed retroviral infection
we have used two different methods, cotransfection and
sequential transfection, to introduce genetically different
retroviral vectors into the host cells. Since plasmid DNA
transfected into eucariotic cells is usually tandemly inte-
grated in a chromosome [16-19], it is expected that
cotransfected vectors will be localized in the same locus of
chromosome and RNA transcribed from these templates
will form a general pool of molecules. In this case, two
genetically different populations of RNA molecules will
ideally overlap. On the other hand, it is unknown whether
the same conditions exist for reassortment of RNA mole-
cules transcribed at different chromosomal locations. The
study of recombination frequencies for retroviral vectors
that are introduced by the cotransfection or sequential
transfection can help to answer this question.
Comparative study of recombination frequencies for 
retroviral vectors with the same and different 
chromosomal locations
In this study Mo-MuLV-based retroviral vectors were used
as partners for recombination. These vectors contained
the Mo-MuLV sequences as follows: the 5' and 3' LTRs, ψ
region, a part of gag-sequences before XhoI site (position
1560 [20]), and 140 bp including the polypurine tract
before 3' LTR (Figure 1). To selectively introduce vectors
into the packaging cell line, pDHEneo contained the neo
gene that was expressed by transcripts initiated from the
long terminal repeat, while pD∆pbsSVpuro contained the
puro gene under control of SV40 early promoter region. In
addition to the differences in selectable markers, the
pD∆pbsSVpuro vector was replication defective due to the
deletion of entire PBS.
Since pD∆pbsSVpuro RNA is impaired at the initiation of
reverse transcription, this function can be restored when
the cDNA initiated on the copackaged pDHEneo RNA is
transferred to the puro RNA template during the first
jump; minus-strand synthesis continues through the puro
gene, and the template shift occurs within the leader
region. Thus, the restoration of retroviral vector contain-
ing the puro gene is possible via homologous recombina-
tion with the neo-containing construct at the sequence
identity in the leader region of the genome.Retrovirology 2005, 2:3 http://www.retrovirology.com/content/2/1/3
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The experimental scheme employed in this study is out-
lined in Figure 2. Retroviral vectors pD∆pbsSVpuro and
pDHEneo were introduced into GP+envAM12 packaging
cells by either the cotransfection or sequential transfection
procedure. For sequential transfection pD∆pbsSVpuro
was first introduced into helper cells. The transfected cells
were placed on puromycin selection and the resistant cell
clones were picked. Viral titers generated from these
clones were analyzed using NIH3T3 cells. None of the cell
clones analyzed produced detectable level of puromycin
titer. Two clones were further used for transfection of
pDHEneo and the G418 resistant clones were selected. For
cotransfection the equal quantities of vector DNA was
used for transfection of helper cells. The cells were first
placed on G418 selection and the resistant cell clones
were further obtained via puromycin selection. After drug
selection, the double-resistant helper cell clones were
isolated.
It was expected that plasmid DNA of retroviral vectors
pDHEneo and pD∆pbsSVpuro cotransfected into the
packaging cell line would be tandemly integrated into the
host genome. To study the integration of plasmid DNA,
the PCR analysis was performed with the primers hybrid-
izing to the 3' end of neo gene (T1, direct, for pDHEneo)
and to the SV40 early promoter region (T2, reverse, for
pD∆pbsSVpuro). Using these primers, the specific PCR
products could be obtained if the pDHEneo and pD∆pb-
sSVpuro are located in the same chromosomal site. On
the other hand, PCR products could be generated with
only one of the primers when identical molecules of plas-
mid DNA were integrated in the opposite orientation.
However, the efficiency of amplification in this case seems
to be very low because such sequences will contain
inverted repeats.
The PCR analysis was performed using chromosomal
DNA prepared from different cell clones generated after
cotransfection or sequential transfection of vectors. PCR
products were separated by gel electrophoresis, trans-
ferred onto nylon membrane and hybridized with 3' neo
specific probe. An example is presented in Figure 3 which
shows that specific PCR products of different size were
obtained only for the cell clone generated after cotransfec-
tion of two vectors. These data are in agreement with early
observations [16-19] and demonstrate that plasmid DNA
transfected into the packaging cells is cointegrated into
the cellular DNA.
We also used RT-PCR-based assay to examine the ratios of
retroviral virion RNA molecules for cell clones generated
by different methods of transfection. Since retroviral
Structures of Mo-MuLV-based retroviral vectors used in this study Figure 1
Structures of Mo-MuLV-based retroviral vectors used in this study. U3, R, U5, regions of long terminal repeat; SV, simian virus 
40 early promoter region; ψ+, extended packaging signal; Neo, neomycin phosphotransferase gene; Puro, puromycin N-acetyl-
transferase gene. ∆pbs and ∆EP indicate that the entire primer binding site and enhancer-promoter sequences from the U3 
region are deleted.
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Experimental scheme to study recombination frequencies for retroviral vectors located in the same or different chromosomal  sites Figure 2
Experimental scheme to study recombination frequencies for retroviral vectors located in the same or different chromosomal 
sites.
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vectors differed by localization of EcoRI sites in the leader
regions, these restriction sites were used as markers to
distinguish the two coamplified PCR products obtained
with primers specific to this region (Figure 4). EcoRI diges-
tion generated 453- and 148-bp fragments from the
pD∆pbsSVpuro PCR products that were readily distin-
guishable from the 515- and 98-bp fragments generated
from the pDHEneo PCR products. Since the only differ-
ences between the neo- and puro-containing RNAs are
nineteen bases that lie within the polymerized region
(PBS was replaced with EcoRI in pD∆pbsSVpuro and one
nucleotide was substituted in the leader region of pDHE-
neo to introduce EcoRI site), these two templates will
amplify with equal efficiency. PCR products obtained
from virion RNA for the two cell clones generated by
sequential transfection and two clones generated by
PCR analysis of plasmid DNA transfected into the packaging cell line GPenv-AM12 Figure 3
PCR analysis of plasmid DNA transfected into the packaging cell line GPenv-AM12. A. Analysis of tandemly integrated plasmid 
DNA. Amplification was performed with a 5' primer specific to neo sequences (T1, unique for pDHEneo) and a 3' primer spe-
cific to SV40 early promoter region (T2, unique for pD∆pbsSVpuro). Membrane was hybridized with 3' neo specific probe gen-
erated from a 150 bp SalI-ClaI fragment of pDHEneo. ST is GPenv-AM12 virus-producing cell clone ST2-1 generated by 
sequential transfection of pDHEneo and pD∆pbsSVpuro, and CT is cell clone CT2 generated by cotransfection of the same 
vectors. Molecular size markers are indicated on the right of the Southern blot. Similar results were obtained when four cell 
clones were analyzed. B. Control of amplification. Primers specific to the 5'- and 3'-end of neo gene (CND and CNR, respec-
tively) were used to generate PCR products (1.63 kb) from ST and CT DNA samples. Membrane was hybridized with the same 
probe as in A. PCR products obtained from 200 and 40 ng of ST DNA sample (line 1 and 2); PCR products obtained from 200 
and 40 ng of CT DNA sample (line 3 and 4). The result shows that specific PCR products could be amplified both from ST and 
CT DNA samples with this set of primers.
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RT-PCR analysis of virion RNAs Figure 4
RT-PCR analysis of virion RNAs. A. Plasmid structures of retroviral leader regions. L1 and L2, primers used for PCR amplifica-
tion; sizes of DNA fragments and positions of EcoRI sites are indicated. B. Leader sequences in virion RNAs were PCR ampli-
fied and analyzed by restriction digestion. PCR products obtained from virion RNAs of ST2-1 and ST2-2 packaging cell clones 
(lines 1 and 3); PCR products obtained from virion RNAs of CT1 and CT2 cell clones (lines 2 and 4); M, molecular weight 
markers. The ratios of puro/neo retroviral RNAs for ST2-1, ST2-2, CT1, and CT2 cell clones were 1.8, 2.0, 1.6, and 2.5, 
respectively.
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cotransfection of retrovital vectors were digested with
EcoRI and the ratio of corresponding DNA fragments was
examined. This analysis showed that ratios of retroviral
RNAs for different cell clones ranged from 1.6 to 2.5
(pD∆pbsSVpuro/pDHEneo) and were the same for two
variants of transfection (Figure 4).
Viral titers generated from three helper cell clones
obtained after sequential transfection and four cell clones
obtained after cotransfection are shown in Table 1. In the
first case the G418 titers varied from 5.0 × 103 to 6.3 × 104
CFU/ml and puromycin titers from 5.1 × 101 to 8.0 × 102
CFU/ml. In the cotransfection experiment, the G418 titers
varied from 3.1 × 104 to 1.1 × 105 CFU/ml and puromycin
titers from 1.4 × 103 to 3.6 × 103 CFU/ml. The frequency
of recombination was calculated from the puromycin-
and G418-drug-resistant colony titers (Table 1). For the
sequential transfection experiment the recombination fre-
quencies ranged from 1 to 1.3 %, with an average of 1.1
%, while recombination frequencies for the cotransfec-
tion experiment ranged from 3.3 to 4.5 %, with an average
of 3.9 %.
The restriction enzyme marker differences in the leader
regions of vectors provided a means to analyze the nature
of recombinants in NIH 3T3 cells examined by PCR assay.
Cellular DNA was analyzed from eight Puror NIH 3T3 cell
clones obtained after infection with viruses produced by
ST2-1 helper cell clone and eight cell clones obtained after
infection with viruses produced by CT1 helper cell clone.
This assay showed that all analyzed proviruses were
recombinants between parental viruses, three of which
were generated by template-switching in the 300 nt DLS
region, and thirteen which were generated by template-
switching in the 1038 nt region of 3' DLS (data not
shown).
These experiments demonstrated that the frequency of
recombination between vectors localized in the same
chromosomal site was about four-fold higher than that of
vectors with different chromosomal locations. These data
suggest that there might be a preference for the formation
of diploid retroviral genome from RNA molecules that are
transcribed on the same DNA template. On the other
hand, it could not be completely excluded that the high
frequency of recombination for retroviral vectors in the
cotransfection experiments occurred during or after trans-
fection procedure.
The use of retroviral vector with the inactivated promoter
To study the possibility of recombination between
cotransfected vectors during or after transfection, we used
the defective vector in which the 5' LTR promoter was
deleted. This vector, pD∆pSVpuro, is almost completely
homologous to pD∆pbsSVpuro with the exception of 194
bp in the U3 region (Figure 1). The efficiency of recombi-
nation during cotransfection for pD∆pSVpuro and
pDHEneo was expected to be similar to that of pD∆pb-
sSVpuro and pDHEneo. However, the restoration of
pD∆pSVpuro during reverse transcription will be limited
by the basal level of cellular transcription since this vector
is transcriptionally defective. Thus, the use of vector with
the inactivated promoter could distinguish between
recombination at the level of DNA and RNA in our exper-
imental system.
Table 1: The comparative study of recombination frequencies for cotransfected and sequentially transfected retroviral vectors
Method of introduction Clone Viral titer (CFU/ml) Recombination frequency* (%)
Puromycin G418
Sequential Transfection:
pD∆pbsSVpuro + pDHEneo ST1-1 5.1 × 101 5.0 × 103 1.0
ST2-1 4.2 × 102 4.2 × 104 1.0
ST2-2 8.0 × 102 6.3 × 104 1.3
Mean ± SE 1.1 ± 0.1
Cotransfection:
pD∆pbsSVpuro + pDHEneo CT1 3.6 × 103 1.1 × 105 3.3
CT2 1.4 × 103 3.1 × 104 4.5
CT3 2.0 × 103 5.5 × 104 3.6
CT4 3.1 × 103 7.4 × 104 4.2
Mean ± SE 3.9 ± 0.3
pD∆pSVpuro + pDHEneo CR1 2.5 × 101 1.0 × 105 0.03
CR2 2.5 × 101 4.8 × 104 0.05
CR3 0.9 × 101 2.9 × 104 0.03
Mean ± SE 0.04 ± 0.01
*The frequency of recombination was calculated as the ratio of puromycin- to G418-drug-resistant colony titer.Retrovirology 2005, 2:3 http://www.retrovirology.com/content/2/1/3
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The introduction of viral vectors into the packaging cell
line, GP+envAM12, allowed selection and propagation of
individual cellular clones under conditions similar to
those in the previous experiments. The resulting viral tit-
ers are shown in Table 1. For three helper cell clones gen-
erated after the cotransfection with pD∆pSVpuro and
pDHEneo the G418 titers varied from 2.9 × 104 to 1.0 ×
105 CFU/ml, with an average 5.9 × 104 CFU/ml, and the
puro titers varied from 0.9 × 101 to 2.5 × 101 CFU/ml, with
an average 2.0 × 101 CFU/ml. The frequency of recombi-
nation for these vectors was 0.04 %. Thus, these results
clearly demonstrated that recombination during cotrans-
fection in our experimental system was a rare event and
the majority of recombinations between cotransfected
vectors occurred during the reverse transcription.
Discussion
In the present work we have examined whether there was
a preference in the formation of homodiploid genomes
when two genetically different retroviral vectors were
located in the different regions of the host genome. Since
plasmid DNA transfected into eucaryotic cells is usually
tandemly integrated [16-19], we have compared the fre-
quencies of recombination for two Mo-MuLV-based retro-
viral vectors introduced into the helper cell line by either
cotransfection or sequential transfection. Our results
showed that cotransfection yielded about four-fold higher
frequency of recombination comparing to sequential
transfection, indicating that diploid retroviral genome is
mainly formed from RNA molecules transcribed on the
same DNA template. To exclude the possibility that
recombination between vectors occurred during the
cotransfection or/and the integration of plasmid DNA
into the helper cell genome, we used a retroviral vector
with the deletion of promoter-enhancer sequences as a
partner for recombination. The 100-fold lower frequency
of recombination for transcriptionally deficient vector,
compared to that of the identical retroviral vector with the
intact promoter, indicated that recombination during
cotransfection was a rare event relative to recombination
during reverse transcription.
Recent studies using the Moloney murine leukemia virus
and the Spleen necrosis virus based vectors demonstrated
that the recombination rate did not increase linearly with
the increasing of marker distance and the multiple recom-
bination events were observed much more often than
could be expected from the frequency of recombination
[10,15,21,22]. From these data it was postulated that the
rate of retroviral recombination is restricted by the size of
the recombining subpopulation [10,15,21]. On the other
hand, the rate of recombination obtained for HIV-1 was
about two to three crossovers per genome per replication
cycle [11,12]. High rate of HIV-1 recombination was also
observed in the experimental system where target
sequences and experimental conditions for recombina-
tion were the same as in Mo-MuLV- and SNV-based stud-
ies [23]. While the rates of intermolecular recombination
for HIV-1 and gammaretrovoruses were different, their
intramolecular template switching frequencies were simi-
lar [14,24].
The preferential formation of homodimers in the mixed
retroviral infection can explain the existence of the recom-
bining subpopulation found for avian and murine retro-
viruses because, in this case, the amount of heterodiploid
virions will be less than expected from the randomly dis-
tributed genomic RNA. Our demonstration of about 4-
fold differences in the frequencies of recombination for
the cotransfected and sequentially transfected retroviral
vectors seems to agree with the data showing that the max-
imal recombination rate for Mo-MuLV was 20 % per
genome per replication cycle [10,22]. These data also indi-
cate that the difference in the recombination frequencies
for gammaretroviruses and HIV-1 could mainly be associ-
ated with the ability of these viruses to copackage two dif-
ferent genomic RNAs.
The possible mechanism explaining the preferential for-
mation of homodimers, as suggested earlier [15], may be
a local transport of RNA transcribed in the same locus of
chromosome from the nucleus to their destination in the
cellular cytoplasm. In the cytoplasm, RNA could be
quickly bound by viral proteins before two different pools
of RNA molecules transcribed in different chromosomal
sites will be equally distributed. The gammaretroviruses
and HIV-1 could differ in the properties of their RNA
transport and distribution in the cellular cytoplasm. For
example, HIV-1 encodes the virus-specific protein Rev
which selectively transports the unspliced viral RNAs from
the nucleus to cytoplasm [25]. Moreover, unspliced HIV-
1 RNAs form a general cytoplasmic pool of molecules
which can further participate in the translation of viral
proteins and/or be packaged in the virions [26]. It was
recently shown that translation of HIV-1 viral RNAs could
precede their packaging [27]. In this case, the translation
of genomic RNAs can provide more time for reassortment
of two different viral RNAs. As an alternative, it can be sug-
gested that the dimerization of genomic RNAs of gamma-
retroviruses occurs immediately after transcription in the
cell nucleus and heterodimerization involves only minor
populations of RNA molecules left in a monomeric form
and/or unstable homodimers.
The diploidy of retroviral genome supposes that two mol-
ecules of RNA could be necessary for replication of virus.
However, it is also possible that diploidy is important for
recombination and evolution of virus since retroviruses
do not have a pool of replicative intermediates that can
undergo recombination [5]. The preferential copackagingRetrovirology 2005, 2:3 http://www.retrovirology.com/content/2/1/3
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of genetically identical retroviral RNAs further argues in
favour of the hypothesis that both RNA molecules are
required in each round of retroviral replication. This
assumption is also in agreement with the results of previ-
ous studies showing the utilization of both HIV-1 RNAs
during reverse transcription [11,12]. It can be suggested
that two genomic molecules of RNA are necessary to
repair frequent breaks in RNAs [28] or the synthesis of
provirus requires involvement of cis-acting elements
present in both RNA molecules.
Upon completion of our manuscript, an article was pub-
lished concluding that dimerization of Mo-MuLV
genomic RNAs is carried out by nonrandom chance [35].
There are several differences in these two studies. In the
cited report, the RNA dimers were examined in the viruses
that were generated by transiently cotransfecting two vec-
tors or were produced by cell clones containing retroviral
vectors integrated in different chromosomal sites. A
model of nonrandom dimerization has been proposed,
where Mo-MuLV genomic RNAs may undergo dimeriza-
tion cotranscriptionally. In our study, the frequencies of
recombination were directly compared for cell clones
where retroviral vectors were integrated in the same or dif-
ferent chromosomal sites. While retroviral vectors inte-
grated in the same chromosomal site were expressed as
independent transcriptional units, the efficiency the het-
erodimer formation was increased about four-fold com-
pared to that of retroviral vectors with different
chromosomal locations. This argues that dimerization of
Mo-MuLV genomic RNAs during cotranscription is not
the main reason for the preferential formation of
homodiploid genomes in Mo-MuLV. In spite of substan-
tial differences in the methods, the estimations of the effi-
ciency of homodimer formation were similar in both
studies. The experimental system presented in our report
could be used to study cellular and viral factors that are
responsible for the preferential copackaging of genetically
identical retroviral RNAs.
Conclusions
The results of this study provide evidence that the Mo-
MuLV genome is mainly formed from RNA molecules
synthesized on the same DNA-provirus. This property of
Mo-MuLV may explain why only small subpopulations of
gammaretroviruses produce recombinants. In this con-
text, the differences in the frequencies of recombination
between HIV-1 and Mo-MuLV may reflect differences in
the ability of these viruses to randomly copackage geneti-
cally distinct RNAs. The preferential formation of
homodiploid genomes in Mo-MuLV also implies that
both molecules of RNA might be required for replication
of the retroviral genome.
Methods
Plasmid constructions
pMOV9 containing the complete copy of Mo-MuLV pro-
virus and retroviral vectors pDneo and pDSVpuro have
been described earlier and were used as the progenitor for
all the constructions [29,30]. pDneo and pDSVpuro con-
tain upstream long terminal repeat (LTR) and ψ+ region
before position 1560 of Mo-MuLV sequences [20], neo-
mycin phosphotransferase gene or puromycin N-acetyl-
transferase gene under control of Simian virus 40 (SV40)
early promoter region, and the Mo-MuLV sequences from
position 7674 including downstream long terminal
repeat. The nucleotides are numbered for the Mo-MuLV
sequences starting from the beginning of R region [20]. To
generate pD∆pbsSVpuro, we first constructed pLTR∆pbs
which contains the LTR and the leader region before posi-
tion 564 of pMOV9 with the deletion of PBS region. For
this purpose we used the PCR to amplify two overlapping
fragments after joining of which the PBS region was sub-
stituted with the EcoRI site. The first PCR fragment was
generated with the primers: U3 SalI 5'-CGCGTCGACA-
GAAAAAGGGGGGAA-3' (sense, positions 7803–7821)
and Rir EcoRI 5'-GCGCGAATTCAATGAAAGACCCCCG-
3' (antisense, positions 130–144); the second PCR frag-
ment was generated with the primers: 3'PBS EcoRI 5'-
GCGCGAATTCCGGGAGACCCCTGCC-3' (sense, posi-
tions 164–178) and L2 5'-GACAAATACAGAAAC-3' (anti-
sense, positions 599–613). PCR fragments were digested
with EcoRI, ligated, and further digested with SalI and
PstI, and cloned into pBluescript KSII+ (Stratagene). The
amplified region of pLTR∆pbs was analyzed by sequenc-
ing. The resulting construct, pD∆pbsSVpuro, was gener-
ated by exchanging the KpnI-PstI (nucleotide positions 32
to 564) fragment of pDSVpuro with the corresponding
fragment of pLTR∆pbs.
pDHEneo is identical to pDneo except the point muta-
tions in the sequences flanking the DLS region. These
mutations converted the Mo-MuLV sequences in this
region into new restriction sites for HindIII and EcoRI. A
description of the cloning steps performed to generate this
vector is available upon request.
To produce pD∆pSVpuro, the enhancer-promoter
sequences of U3 region in pD∆pbsSVpuro were deleted.
For this purpose the 3.4 kb SacI-BamHI fragment contain-
ing 36 bp of 5' U3 region starting from SacI site and
including all other vector sequences of pD∆pbsSVpuro
was inserted into the SacI and BamHI sites of pTZ18
plasmid.
All DNA manipulations were performed by standard pro-
cedures [31].Retrovirology 2005, 2:3 http://www.retrovirology.com/content/2/1/3
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Analysis of integrated plasmid DNA
Genomic DNA purification and hybridization were per-
formed by standard molecular techniques [31]. DNA pre-
pared from double-drug-resistant cell clones was used as a
substrate for PCR. Integrated plasmid DNA was amplified
using a 3' neo-specific sense primer T1 (5'-AGTGCAAATC-
CGTCGGCAT-3') and an antisense primer T2 (5'-GAG-
GCGGCCTCGGCCTC-3') within the SV40 early
promoter. The sequences of neo gene in proviral DNA
were PCR amplified using primers CND (5'-CACGCT-
GCCGCAAGCACTCA-3') and CNR (5'-TGGGTGGTGAG-
CAGCTCGCC-3'). PCR was performed in 10 mM Tris (pH
8.3), 50 mM KCl, 2 mMMgCl2, 200 µM each dNTP, 1 %
DMSO, 100 nM primers for 20 cycles (94°C 1 min, 50°C
1 min, 72°C 8 min). The products were separated on 0.8
% agarose gel, transferred onto nylon membrane
(Hybond-N, Amersham), and hybridized with neo-spe-
cific probe (150 bp SalI-ClaI fragment of pDHEneo).
Probes were generated by the random-primer method
with [α32P] dATP [32].
RT-PCR analysis
Virion RNA was purified from filtered culture medium
from transfected cells and used in RT-PCR assays [31].
Briefly, RNA samples were reverse-transcribed in a 20-µl
reaction with Superscript II (Life Technologies), using an
antisense gag-specific primer (L2) beginning at nt 613 (5'-
CAAAGACATAAACAG-3'). A third of the resultant cDNA
was subjected to PCR (94°C for 1 min, 50°C for 1 min,
72°C for 1 min, for 30 cycles) with AmpliTaq DNA
polymerase (Perkin-Elmer), using the same primer that
was used in the RT reaction and paired with a sense R-spe-
cific primer (L1) beginning at nt 1 (5'-GCGCCAGTCCTC-
CGA-3'). PCR products were digested with 10 units of
EcoRI (Fermentas) according to the manufacturer's rec-
ommendations and analyzed by 2 % agarose gel. A Gel-
Doc™ EQ system (Biorad) with SigmaGel v.1.0 software
(Jandel Scientific) was used to quantitate the ethidium
bromide fluorescence intensity of each band.
Cells, DNA transfection, and virus propagation
NIH3T3 (murine cell line) and GP+envAM12 (ampho-
tropic 3T3-based packaging cell line with MLV Gag + Pol
and Env genes) [33] were grown in Dulbecco's modified
Eagle's medium supplemented with 10 % fetal calf serum.
The cell clones producing transfected vectors were estab-
lished by transfecting GP+envAM12 cells with vector plas-
mids using the dimethyl sulfoxide-polybrene method
[34]. Puromycin-resistant cells were selected in 2.5 or 1.5
µg/ml puromycin (Sigma) for GPenv-AM12 or NIH3T3-
derived cells, respectively. Geneticin selection was per-
formed at 800 µg/ml (GP+envAM12) or 600 µg/ml
(NIH3T3) of G418 (Gibco).
Viral infection was performed immediately after harvest-
ing the virus. The supernatants were harvested from 90 %
confluent stable producer cell clones after 16 hour inter-
vals and filtered through the 0.45 µm filters. Infections
were performed in the presence of 8 µg/ml polybrene
(Sigma) for two hours at 37°C. Puromycin- and G418-
resistant cfu titers were determined using the infection of
NIH3T3 cells by end-point dilution.
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